ArticleTranslational cancer research2019

miR-30b suppresses the progression of breast cancer through inhibition of the PI3K/Akt signaling pathway by targeting Derlin-1.

Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.